Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Agios Pharmaceuticals

    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    14 Million USD
    Annual Operating Income in USD
    -389 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
  2. Thonburi Healthcare Group Public Company

    World Rank (Jan-05-2024)
    7,267
    Market Cap (Jan-05-2024)
    1.337 Billion USD
    World Rank (Jul-30-2023)
    6,431
    Market Cap (Jul-30-2023)
    1.664 Billion USD
    World Rank (Dec-25-2022)
    6,320
    Market Cap (Dec-25-2022)
    1.589 Billion USD
    World Rank (Jan-07-2022)
    9,734
    Market Cap (Jan-07-2022)
    0.95 Billion USD
    Annual Revenue in USD
    300 Million USD
    Annual Net Income in USD
    37 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. Sumitomo Pharma Co. Ltd

    World Rank (Jan-05-2024)
    7,290
    Market Cap (Jan-05-2024)
    1.330 Billion USD
    World Rank (Jul-30-2023)
    6,035
    Market Cap (Jul-30-2023)
    1.845 Billion USD
    World Rank (Dec-25-2022)
    4,078
    Market Cap (Dec-25-2022)
    2.998 Billion USD
    World Rank (Jan-07-2022)
    3,494
    Market Cap (Jan-07-2022)
    4.62 Billion USD
    Annual Revenue in USD
    4,087 Million USD
    Annual Net Income in USD
    412 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Sumitomo Dainippon Pharma is a Pharmaceutical company. It manufactures and sales pharmaceuticals, food ingredients, food additives, veterinary medicines and others. The company has market capitalization is 22.4 billion yen and has around 3,074 employees on standalone basis and has 6,646 employees on consolidated basis as on December 2020. The headquarters is in Japan.

    SUMITOMO DAINIPPON PHARMA was renamed to SUMITOMO PHARMA CO., LTD in April-2022.

  4. North China Pharmaceutical Company. Ltd

    World Rank (Jan-05-2024)
    7,291
    Market Cap (Jan-05-2024)
    1.330 Billion USD
    World Rank (Jul-30-2023)
    7,218
    Market Cap (Jul-30-2023)
    1.385 Billion USD
    World Rank (Dec-25-2022)
    6,099
    Market Cap (Dec-25-2022)
    1.668 Billion USD
    World Rank (Jan-07-2022)
    4,688
    Market Cap (Jan-07-2022)
    3.14 Billion USD
    Annual Revenue in USD
    975 Million USD
    Annual Net Income in USD
    3 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  5. Pharvaris N.V.

    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
  6. Vetoquinol SA

    World Rank (Jan-05-2024)
    7,306
    Market Cap (Jan-05-2024)
    1.324 Billion USD
    World Rank (Jul-30-2023)
    7,744
    Market Cap (Jul-30-2023)
    1.224 Billion USD
    World Rank (Dec-25-2022)
    7,941
    Market Cap (Dec-25-2022)
    1.096 Billion USD
    World Rank (Jan-07-2022)
    6,843
    Market Cap (Jan-07-2022)
    1.74 Billion USD
    Annual Revenue in USD
    594 Million USD
    Annual Operating Income in USD
    93 Million USD
    Annual Net Income in USD
    53 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
  7. BioCryst Pharmaceuticals

    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    270 Million USD
    Annual Operating Income in USD
    -148 Million USD
    Annual Net Income in USD
    -247 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  8. Caplin Point Laboratories

    World Rank (Jan-05-2024)
    7,323
    Market Cap (Jan-05-2024)
    1.320 Billion USD
    World Rank (Jul-30-2023)
    9,896
    Market Cap (Jul-30-2023)
    0.804 Billion USD
    World Rank (Dec-25-2022)
    10,820
    Market Cap (Dec-25-2022)
    0.647 Billion USD
    World Rank (Jan-07-2022)
    10,208
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Annual Revenue in USD
    158 Million USD
    Annual Net Income in USD
    38 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
  9. Protagonist Therapeutics

    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    27 Million USD
    Annual Operating Income in USD
    -131 Million USD
    Annual Net Income in USD
    -127 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

  10. Elion Energy Company

    World Rank (Jan-05-2024)
    7,356
    Market Cap (Jan-05-2024)
    1.310 Billion USD
    World Rank (Jul-30-2023)
    6,379
    Market Cap (Jul-30-2023)
    1.684 Billion USD
    World Rank (Dec-25-2022)
    5,326
    Market Cap (Dec-25-2022)
    2.074 Billion USD
    World Rank (Jan-07-2022)
    4,689
    Market Cap (Jan-07-2022)
    3.14 Billion USD
    Headquarters Country

Share

Ads